Annual EBITDA
$1.48 B
-$280.50 M-15.93%
December 1, 2024
Summary
- As of March 6, 2025, EW annual EBITDA is $1.48 billion, with the most recent change of -$280.50 million (-15.93%) on December 1, 2024.
- During the last 3 years, EW annual EBITDA has fallen by -$375.10 million (-20.22%).
- EW annual EBITDA is now -23.16% below its all-time high of $1.93 billion, reached on December 31, 2022.
Performance
EW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$353.30 M
-$75.50 M-17.61%
December 1, 2024
Summary
- As of March 6, 2025, EW quarterly EBITDA is $353.30 million, with the most recent change of -$75.50 million (-17.61%) on December 1, 2024.
- Over the past year, EW quarterly EBITDA has dropped by -$75.50 million (-17.61%).
- EW quarterly EBITDA is now -57.80% below its all-time high of $837.20 million, reached on December 31, 2014.
Performance
EW Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$1.68 B
-$169.60 M-9.19%
December 1, 2024
Summary
- As of March 6, 2025, EW TTM EBITDA is $1.68 billion, with the most recent change of -$169.60 million (-9.19%) on December 1, 2024.
- Over the past year, EW TTM EBITDA has dropped by -$169.60 million (-9.19%).
- EW TTM EBITDA is now -15.24% below its all-time high of $1.98 billion, reached on September 30, 2022.
Performance
EW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EW EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.9% | -17.6% | -9.2% |
| 3 y3 years | -20.2% | -17.6% | -9.2% |
| 5 y5 years | +15.9% | -17.6% | -9.2% |
EW EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -23.2% | at low | -33.3% | at low | -15.2% | at low |
| 5 y | 5-year | -23.2% | +42.4% | -33.3% | +3542.3% | -15.2% | +61.1% |
| alltime | all time | -23.2% | +1725.0% | -57.8% | +1073.3% | -15.2% | +3541.5% |
Edwards Lifesciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.48 B(-15.9%) | $353.30 M(-17.6%) | $1.68 B(-9.2%) |
| Sep 2024 | - | $428.80 M(+2.9%) | $1.84 B(+1.3%) |
| Jun 2024 | - | $416.80 M(-12.5%) | $1.82 B(-0.2%) |
| Mar 2024 | - | $476.20 M(-8.9%) | $1.82 B(+0.5%) |
| Dec 2023 | $1.76 B(-8.6%) | $522.90 M(+29.1%) | $1.82 B(+2.4%) |
| Sep 2023 | - | $405.00 M(-3.7%) | $1.77 B(-4.6%) |
| Jun 2023 | - | $420.60 M(-10.1%) | $1.86 B(-3.0%) |
| Mar 2023 | - | $467.80 M(-2.5%) | $1.92 B(-0.5%) |
| Dec 2022 | $1.93 B(+3.8%) | $480.00 M(-2.0%) | $1.93 B(-2.5%) |
| Sep 2022 | - | $489.70 M(+2.3%) | $1.98 B(+3.1%) |
| Jun 2022 | - | $478.80 M(+0.2%) | $1.92 B(+0.1%) |
| Mar 2022 | - | $477.70 M(-9.9%) | $1.92 B(+3.2%) |
| Dec 2021 | $1.86 B(+78.4%) | $530.00 M(+23.3%) | $1.86 B(+39.0%) |
| Sep 2021 | - | $429.70 M(-10.0%) | $1.33 B(+3.6%) |
| Jun 2021 | - | $477.70 M(+14.3%) | $1.29 B(+21.0%) |
| Mar 2021 | - | $417.80 M(+4207.2%) | $1.06 B(+2.4%) |
| Dec 2020 | $1.04 B(-18.6%) | $9.70 M(-97.5%) | $1.04 B(-22.9%) |
| Sep 2020 | - | $382.80 M(+50.5%) | $1.35 B(+4.6%) |
| Jun 2020 | - | $254.30 M(-35.3%) | $1.29 B(-3.7%) |
| Mar 2020 | - | $392.90 M(+23.1%) | $1.34 B(+4.9%) |
| Dec 2019 | $1.28 B(+46.9%) | $319.20 M(-1.2%) | $1.28 B(+29.3%) |
| Sep 2019 | - | $323.00 M(+6.2%) | $987.60 M(+5.7%) |
| Jun 2019 | - | $304.20 M(-7.8%) | $934.20 M(+1.8%) |
| Mar 2019 | - | $330.10 M(+989.4%) | $917.70 M(+5.6%) |
| Dec 2018 | $868.70 M(-23.8%) | $30.30 M(-88.8%) | $868.70 M(-23.5%) |
| Sep 2018 | - | $269.60 M(-6.3%) | $1.14 B(+2.5%) |
| Jun 2018 | - | $287.70 M(+2.3%) | $1.11 B(+1.6%) |
| Mar 2018 | - | $281.10 M(-5.4%) | $1.09 B(-4.4%) |
| Dec 2017 | $1.14 B(+37.6%) | $297.20 M(+23.1%) | $1.14 B(+9.6%) |
| Sep 2017 | - | $241.40 M(-10.8%) | $1.04 B(+2.7%) |
| Jun 2017 | - | $270.70 M(-18.1%) | $1.01 B(+7.6%) |
| Mar 2017 | - | $330.70 M(+67.6%) | $940.60 M(+13.6%) |
| Dec 2016 | $828.30 M(+17.4%) | $197.30 M(-7.6%) | $828.30 M(+1.4%) |
| Sep 2016 | - | $213.60 M(+7.3%) | $817.10 M(+5.1%) |
| Jun 2016 | - | $199.00 M(-8.9%) | $777.80 M(+4.8%) |
| Mar 2016 | - | $218.40 M(+17.4%) | $742.40 M(+5.2%) |
| Dec 2015 | $705.40 M(-42.6%) | $186.10 M(+6.8%) | $705.40 M(-48.0%) |
| Sep 2015 | - | $174.30 M(+6.5%) | $1.36 B(+2.0%) |
| Jun 2015 | - | $163.60 M(-9.8%) | $1.33 B(+2.2%) |
| Mar 2015 | - | $181.40 M(-78.3%) | $1.30 B(+5.8%) |
| Dec 2014 | $1.23 B(+110.6%) | $837.20 M(+467.6%) | $1.23 B(+110.2%) |
| Sep 2014 | - | $147.50 M(+8.9%) | $585.20 M(+4.5%) |
| Jun 2014 | - | $135.40 M(+23.4%) | $560.20 M(-1.0%) |
| Mar 2014 | - | $109.70 M(-43.0%) | $566.00 M(-3.1%) |
| Dec 2013 | $583.90 M(+30.8%) | $192.60 M(+57.2%) | $583.90 M(+11.6%) |
| Sep 2013 | - | $122.50 M(-13.2%) | $523.30 M(+2.7%) |
| Jun 2013 | - | $141.20 M(+10.7%) | $509.50 M(+7.6%) |
| Mar 2013 | - | $127.60 M(-3.3%) | $473.40 M(+6.2%) |
| Dec 2012 | $446.30 M | $132.00 M(+21.4%) | $445.70 M(+12.0%) |
| Sep 2012 | - | $108.70 M(+3.4%) | $398.00 M(+10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $105.10 M(+5.2%) | $361.80 M(+4.9%) |
| Mar 2012 | - | $99.90 M(+18.5%) | $345.00 M(+0.1%) |
| Dec 2011 | $344.70 M(+5.4%) | $84.30 M(+16.3%) | $344.70 M(-0.5%) |
| Sep 2011 | - | $72.50 M(-17.9%) | $346.40 M(-2.2%) |
| Jun 2011 | - | $88.30 M(-11.3%) | $354.20 M(+2.2%) |
| Mar 2011 | - | $99.60 M(+15.8%) | $346.70 M(+6.1%) |
| Dec 2010 | $327.10 M(-10.6%) | $86.00 M(+7.1%) | $326.90 M(+2.8%) |
| Sep 2010 | - | $80.30 M(-0.6%) | $318.00 M(-8.7%) |
| Jun 2010 | - | $80.80 M(+1.3%) | $348.20 M(+0.8%) |
| Mar 2010 | - | $79.80 M(+3.5%) | $345.60 M(-5.5%) |
| Dec 2009 | $365.80 M(+61.0%) | $77.10 M(-30.2%) | $365.80 M(+10.4%) |
| Sep 2009 | - | $110.50 M(+41.3%) | $331.20 M(+18.8%) |
| Jun 2009 | - | $78.20 M(-21.8%) | $278.80 M(+3.8%) |
| Mar 2009 | - | $100.00 M(+135.3%) | $268.60 M(+22.7%) |
| Dec 2008 | $227.20 M(-0.1%) | $42.50 M(-26.9%) | $218.90 M(-7.0%) |
| Sep 2008 | - | $58.10 M(-14.6%) | $235.50 M(+3.3%) |
| Jun 2008 | - | $68.00 M(+35.2%) | $228.00 M(+3.3%) |
| Mar 2008 | - | $50.30 M(-14.9%) | $220.80 M(-3.4%) |
| Dec 2007 | $227.40 M(-1.1%) | $59.10 M(+16.8%) | $228.50 M(+0.6%) |
| Sep 2007 | - | $50.60 M(-16.8%) | $227.10 M(-1.5%) |
| Jun 2007 | - | $60.80 M(+4.8%) | $230.50 M(+0.4%) |
| Mar 2007 | - | $58.00 M(+0.5%) | $229.60 M(-8.8%) |
| Dec 2006 | $230.00 M(-0.6%) | $57.70 M(+6.9%) | $251.80 M(-1.4%) |
| Sep 2006 | - | $54.00 M(-9.8%) | $255.40 M(-0.0%) |
| Jun 2006 | - | $59.90 M(-25.3%) | $255.50 M(-0.1%) |
| Mar 2006 | - | $80.20 M(+30.8%) | $255.80 M(+10.4%) |
| Dec 2005 | $231.50 M(+10.2%) | $61.30 M(+13.3%) | $231.80 M(+3.1%) |
| Sep 2005 | - | $54.10 M(-10.1%) | $224.90 M(+1.6%) |
| Jun 2005 | - | $60.20 M(+7.1%) | $221.40 M(+3.1%) |
| Mar 2005 | - | $56.20 M(+3.3%) | $214.80 M(+10.3%) |
| Dec 2004 | $210.10 M(+14.2%) | $54.40 M(+7.5%) | $194.70 M(+1.9%) |
| Sep 2004 | - | $50.60 M(-5.6%) | $191.00 M(+3.7%) |
| Jun 2004 | - | $53.60 M(+48.5%) | $184.20 M(+6.5%) |
| Mar 2004 | - | $36.10 M(-28.8%) | $173.00 M(-4.3%) |
| Dec 2003 | $184.00 M(+98.9%) | $50.70 M(+15.8%) | $180.70 M(+5.1%) |
| Sep 2003 | - | $43.80 M(+3.3%) | $172.00 M(+76.6%) |
| Jun 2003 | - | $42.40 M(-3.2%) | $97.40 M(+1.8%) |
| Mar 2003 | - | $43.80 M(+4.3%) | $95.70 M(+3.5%) |
| Dec 2002 | $92.50 M(+14.1%) | $42.00 M(-236.4%) | $92.50 M(+2.5%) |
| Sep 2002 | - | -$30.80 M(-175.7%) | $90.20 M(-42.0%) |
| Jun 2002 | - | $40.70 M(+0.2%) | $155.40 M(+98.2%) |
| Mar 2002 | - | $40.60 M(+2.3%) | $78.40 M(-3.3%) |
| Dec 2001 | $81.10 M(-52.0%) | $39.70 M(+15.4%) | $81.10 M(-20.5%) |
| Sep 2001 | - | $34.40 M(-194.8%) | $102.00 M(-4.9%) |
| Jun 2001 | - | -$36.30 M(-183.8%) | $107.30 M(-38.5%) |
| Mar 2001 | - | $43.30 M(-28.5%) | $174.60 M(-1.5%) |
| Dec 2000 | $169.00 M(-15.9%) | $60.60 M(+52.6%) | $177.30 M(+51.9%) |
| Sep 2000 | - | $39.70 M(+28.1%) | $116.70 M(+51.6%) |
| Jun 2000 | - | $31.00 M(-32.6%) | $77.00 M(+67.4%) |
| Mar 2000 | - | $46.00 M | $46.00 M |
| Dec 1999 | $201.00 M | - | - |
FAQ
- What is Edwards Lifesciences annual EBITDA?
- What is the all time high annual EBITDA for Edwards Lifesciences?
- What is Edwards Lifesciences annual EBITDA year-on-year change?
- What is Edwards Lifesciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly EBITDA year-on-year change?
- What is Edwards Lifesciences TTM EBITDA?
- What is the all time high TTM EBITDA for Edwards Lifesciences?
- What is Edwards Lifesciences TTM EBITDA year-on-year change?
What is Edwards Lifesciences annual EBITDA?
The current annual EBITDA of EW is $1.48 B
What is the all time high annual EBITDA for Edwards Lifesciences?
Edwards Lifesciences all-time high annual EBITDA is $1.93 B
What is Edwards Lifesciences annual EBITDA year-on-year change?
Over the past year, EW annual EBITDA has changed by -$280.50 M (-15.93%)
What is Edwards Lifesciences quarterly EBITDA?
The current quarterly EBITDA of EW is $353.30 M
What is the all time high quarterly EBITDA for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly EBITDA is $837.20 M
What is Edwards Lifesciences quarterly EBITDA year-on-year change?
Over the past year, EW quarterly EBITDA has changed by -$75.50 M (-17.61%)
What is Edwards Lifesciences TTM EBITDA?
The current TTM EBITDA of EW is $1.68 B
What is the all time high TTM EBITDA for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM EBITDA is $1.98 B
What is Edwards Lifesciences TTM EBITDA year-on-year change?
Over the past year, EW TTM EBITDA has changed by -$169.60 M (-9.19%)